Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus

Patent metadata

Field	Value
Publication number	US-9547006-B2
Application number	US-201414455530-A
Country	US
Kind code	B2
Filing date	Aug 8, 2014
Priority date	Aug 8, 2013
Publication date	Jan 17, 2017
Grant date	Jan 17, 2017

Abstract

A massive clonal expansion of activated CD8 + T-cells with increased frequency of HPV 16-specific CD8 + T-cells was discovered to be a characteristic of oral lichen planus (OLP), indicating a causal link between HPV infection and the dysimmune process. The invention relates to compositions and methods for the diagnosis and treatment of OLP patients.

First claim

We claim:

1. A method for treatment of an oral lichen planus patient comprising:
providing a cell sample from an oral lichen planus patient;
detecting the presence of an immune response against a human papilloma virus infection in the cell sample by sequencing a CDR3β sequence of a TCRVβ3 gene segment in T cells of the cell sample expressing a TCRVβ3 specific for the E7 11-20 immunodominant peptide of HPV16;
treating the patient with an anti-HPV treatment; and
detecting a reduction in an oral lichen planus symptom.

2. The method of claim 1 , wherein the cell sample is a lesion from an oral lichen planus patient.

3. The method of claim 1 , wherein the cell sample is a blood sample from an oral lichen planus patient.

4. The method of claim 1 , wherein the human papilloma virus is of a type selected from types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 69, 73, and 82.

5. The method of claim 1 , wherein the anti-HPV treatment is selected from a treatment with a composition comprising the major capsid protein L1 of HPV types 6, 11, 16, and 18; a treatment with a composition comprising the major capsid protein L1 of HPV types 16, and 18; and a treatment with at least one chimeric recombinant Bordetella sp. adenylate cyclase (CyaA) protein or fragment thereof, the CyaA protein or fragment thereof comprising at least one inserted human papilloma virus (HPV) E7 epitope.

6. The method of claim 1 , wherein the CDR3β sequence of the TCRVβ3 gene segment in the T cells of the cell sample comprises any one of SEQ ID NOs 1-10.

7. The method of claim 1 , comprising detecting a clonal population of CD8+TCRVβ3+ T cells expressing a TCRVβ3 specific for the E7 11-20 immunodominant peptide of HPV16 in the cell sample.

8. A method for treatment of an oral lichen planus patient comprising:
providing a cell sample from an oral lichen planus patient;
detecting the presence of an immune response against a human papilloma virus infection in the cell sample by sequencing a CDR3β sequence of a TCRVβ3 gene segment in T cells of the cell sample expressing a TCRVβ3 specific for the E7 11-20 immunodominant peptide of HPV16; and
treating the patient with an anti-HPV treatment.

Assignees

• Pasteur Institut
• Inst Nat De La Sante Et De La Rech Medicale (Inserm)
• Univ Paris Diderot—Paris 7
• Assistance-Publique Hopitaux De Paris
• Assist Publique—Hopitaux De Paris

Inventors

• Gougeon Marie-Lise
• Viguier Manuelle
• Bachelez Herve
• Fazilleau Nicolas

Classifications

• G01N2800/18

  Dental and oral disorders · CPC title

• G01N33/5008

  for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics · CPC title

• G01N33/56972

  White blood cells · CPC title

• C12Q1/708

  for papilloma · CPC title

• A61K2039/572

  cytotoxic response · CPC title